Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration.
Saved in:
| Title: | Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration. |
|---|---|
| Authors: | Chang LK; Vitreous, Retina, Macula Consultants of New York, 460 Park Ave, Fifth Floor, New York, NY 10022, USA., Spaide RF, Brue C, Freund KB, Klancnik JM Jr, Slakter JS |
| Source: | Archives of ophthalmology (Chicago, Ill. : 1960) [Arch Ophthalmol] 2008 Jul; Vol. 126 (7), pp. 941-5. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7706534 Publication Model: Print Cited Medium: Internet ISSN: 1538-3601 (Electronic) Linking ISSN: 00039950 NLM ISO Abbreviation: Arch Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
